COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk

Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.

Read the full article here

Related Articles